Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
about
Production of EV71 vaccine candidatesEV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseasesSeroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infantsEV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.Establishment of national reference for bunyavirus nucleic acid detection kits for diagnosis of SFTS virus.Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDCComparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice.EV71 vaccine, an invaluable gift for children.Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China.The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn miceEnterovirus 71 viral capsid protein linear epitopes: identification and characterization.Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches.Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNAImmunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial.Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months.Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months.Progress on the research and development of inactivated EV71 whole-virus vaccines.Development of a sandwich ELISA for the quantification of enterovirus 71.Progress on the research and development of human enterovirus 71 (EV71) vaccines.Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.Update on the development of enterovirus 71 vaccines.Chinese vaccine products go global: vaccine development and quality control.Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.An epidemic of coxsackievirus B3 infection in infants and children in Jiangsu Province, China: a prospective cohort study.2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children.A booster dose of an inactivated enterovirus 71 vaccine in chinese young children: a randomized, double-blind, placebo-controlled clinical trial.A safety study of inactivated Enterovirus 71 vaccine.A cross-sectional seroepidemiology study of EV-D68 in China.
P2860
Q26866091-643B6924-30EB-4BD1-88CE-68DDF4668DB2Q28076658-8A17F8C9-319D-4FFA-B808-7F39BE7312B2Q28547485-36275AF4-86B6-41A5-A583-E9D8476B8654Q28729190-8B318454-51F1-4E84-A805-FEC7075CCC98Q30383172-2B656DC4-6AB4-40EC-A02D-047AE83AE41BQ30922949-FA6AC63B-2353-472B-B133-73363063ED2DQ33439350-B9F62008-2886-4844-BBE1-D48E81DE0ABBQ34289974-F2A79FF7-C4A9-4A7D-B81B-2AC481928DD2Q34430681-E64ECE14-DB2A-4DE5-91E5-4D95F1198A80Q34540559-59678314-BEAF-4DC7-A667-D2B195BAC920Q34820250-F6636FBE-F12D-4B59-B242-1C827C661373Q35048558-B6715ADC-461F-44EF-AE49-5EC944030BF4Q35689929-C24A0E5A-299A-41C7-9DE5-690FB7B00CECQ35797988-0659C568-BEDF-4DBD-A658-13F7D716F633Q35806448-1541ADD7-4335-41F5-ADF7-D5A4E5972E83Q35991169-C2D40007-753E-4276-B020-8F4C96F941C8Q36256455-68CC07FC-4D2B-45D4-82F1-0DEB8563FAE9Q36389012-C1B574FD-CCEC-435E-8400-BF02A73AA1E4Q36479953-06D65F1F-7046-4FEC-ACBE-F8917969693DQ36977606-316336EB-0AEB-4059-A722-3B179B875524Q37130739-B23DE14F-257F-478D-84A7-B45CE9D2DD79Q37469307-9EE9C5A5-EAD5-4AFF-BBF2-1D1B961102C2Q37530094-15BC458D-3B64-40ED-A7CF-F646E1C81C89Q37681184-93358CD1-90CD-4CFE-9062-01593E66FD81Q38068107-9C00FA4C-440E-440F-A271-E8956C903112Q38195326-73C5BB1B-C3B1-4F51-AFF2-9AFD1C0F62FFQ38225695-AFA3EB95-3B7B-458E-8CB5-1C8E631238D1Q38362086-4E0AD71B-5B65-4D1C-89D2-37D56BA1B9ACQ38840182-0B18407D-D014-4208-84F9-5787E3824F6DQ39884542-67669DFB-8E13-4C2D-8F4B-C444BEFDCC64Q40376000-C2EE5E63-2E5F-4EF7-A40E-968DB08DC269Q40955592-29866B32-C018-460A-BADA-47E6575E6BFEQ42231743-0BD0B31F-F1FD-4FCA-9000-2430670D1350Q46825689-A1F4CC55-0D6D-447D-8078-6DEE18C4949DQ55346626-B97EEC22-C3C1-4158-AE35-10253A66532C
P2860
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
description
article
@en
im Dezember 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2011
@uk
name
Establishing China's national ...... enterovirus 71 (EV71) vaccines
@en
Establishing China's national ...... r evaluation of enterovirus 71
@nl
type
label
Establishing China's national ...... enterovirus 71 (EV71) vaccines
@en
Establishing China's national ...... r evaluation of enterovirus 71
@nl
prefLabel
Establishing China's national ...... enterovirus 71 (EV71) vaccines
@en
Establishing China's national ...... r evaluation of enterovirus 71
@nl
P2093
P1433
P1476
Establishing China's national ...... enterovirus 71 (EV71) vaccines
@en
P2093
Chenghong Dong
Fengxiang Li
Junzhi Wang
Qunying Mao
Weidong Yin
Xinliang Shen
P304
P356
10.1016/J.VACCINE.2011.10.018
P407
P577
2011-12-06T00:00:00Z